Collexis' Expert Profiling for the UK's Biomedical Research Community

Collexis Holdings, Inc.A new agreement was announced between Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic knowledge discovery software and expert profiles, and JISC Collections for an online resource, which aims to encourage greater collaboration and expand scientific knowledge amongst the biomedical research community in the UK. For specially negotiated subscription fees, researchers, teaching staff and students at universities and research councils in the UK, will be able to access Collexis' Expert Profiling. This online resource enables users to quickly identify experts within their institution as well as identify, locate and collaborate with other experts from around the world.

Using the Collexis system, subscribing institutions can create expert profiles of investigators, researchers and departments to disseminate ground-breaking research and biomedical advances. These profiles are generated using researchers’ publications from a variety of sources. Profiles are then available to all researchers, allowing them to easily find what is being published, what researchers are active and the pace of research in a particular area of interest.

"Collexis' Expert Profiling System fosters collaboration among researchers, allowing them to leverage the information of their colleagues and work to enhance, stimulate and create new ideas and discoveries," said Bill Kirkland, CEO of Collexis Holdings, Inc. "We are excited about working with JISC Collections to create internal expert profiling systems that bridge the gap between departments, cooperating organisations, basic research and clinical research."

Lorraine Estelle, CEO of JISC Collections, says that this agreement will "save users researchers time identifying expertise within their institutions, but provides opportunities for research and help widen access to essential sources of biomedical research. We also hope that it will encourage greater collaboration across our community through increased awareness and through the sharing of research outputs amongst institutions."

In addition to the new agreement with JISC Collections, Collexis Holdings Inc. is bringing its innovative technology to other research organisations and universities worldwide, including the Mayo Clinic Libraries; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb; Lockheed Martin; World Health Organization, National Institutes of Health; and U.S. Department of Defense.

Collexis' Expert Profiling is available to all staff and students within a subscribing university or research council institution in the UK. Institutions wanting access to the service will be required to pay an annual subscription fee. For further information, please go to: http://www.jisccollections. ac.uk/catalogue/collexis_expert.

Related news articles:

About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks". Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

About JISC Collections
JISC Collections was established as a mutual trading company by the UK further and higher education funding councils in 2006 to negotiate with publishers of online information and other owners of digital content. The range of resources licensed for use by such agreements constitutes a large national collection of online resources for education and research. JISC Collections is funded by JISC. For further information, please go to http://www.jisc-collections.ac.uk.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Stepping for Digital Rewards

Walking is well known to have significant health benefits, but few people achieve the daily recommended steps. Fortunately, mobile health (mHealth) applications have emerged as promising tools to promote physical...